TNFRSF1B and neoplasm: More importantly, the proportion of tumor-infiltrating IFNγ-expressing CD8+ CTLs was increased by 2-4 folds in TNFR2-deficient tumors, compared with those in W.T. tumors (Figure 7, P < 0.01-0.001).